Catalyst Wire Dossier Catalyst Wire Dossier

BGT007

· BioSyngen Pte Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BGT007, covering 2024-10-16 to 2024-10-16. Get the full timeline:

Most recent: Clinical Trial Update: BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies [EARLY_Phase 1]

See pricing